Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “CART Cells”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Ended earlyNCT04025216
What this trial is testing

CART-TnMUC1 in Patients With TnMUC1-Positive Advanced Cancers

Who this might be right for
Non-Small Cell Lung CancerOvarian CancerFallopian Tube Cancer+3 more
Kite, A Gilead Company 16
Early research (Phase 1)Looking for participantsNCT06201416
What this trial is testing

Study of Single Doses of SBT777101 in Subjects With Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
Sonoma Biotherapeutics, Inc. 48
Early research (Phase 1)Study completedNCT04768608
What this trial is testing

PD1 Integrated Anti-PSMA CART in Treating Patients With Castrate-Resistant Prostate Cancer

Who this might be right for
Castrate-Resistant Prostate Cancer
Zhejiang University 3
Testing effectiveness (Phase 2)UnknownNCT02862704
What this trial is testing

MG7 Redirected Autologous T Cells for Advanced MG7 Positive Liver Metastases(MG7-CART)

Who this might be right for
Liver Metastases
Xijing Hospital 20
Early research (Phase 1)Active Not RecruitingNCT06973096
What this trial is testing

CART-EGFR-IL13Ra2 in Newly Diagnosed GBM Following Initial Radiotherapy

Who this might be right for
Glioblastoma
University of Pennsylvania 9
Early research (Phase 1)Active Not RecruitingNCT03089203
What this trial is testing

CART-PSMA-TGFβRDN Cells for Castrate-Resistant Prostate Cancer

Who this might be right for
Prostate Cancer
University of Pennsylvania 23
Early research (Phase 1)Active Not RecruitingNCT03549442
What this trial is testing

Up-front CART-BCMA With or Without huCART19 in High-risk Multiple Myeloma

Who this might be right for
Multiple Myeloma
University of Pennsylvania 40
Testing effectiveness (Phase 2)UnknownNCT03614858
What this trial is testing

CD19/CD22-targeted Chimeric Antigen Receptor Engineered T Cell (CART) in B-Cell Acute Lymphoblastic Leukemia.

Who this might be right for
Leukemia, B-cell
Shanghai Unicar-Therapy Bio-medicine Technology Co.,Ltd 20
Testing effectiveness (Phase 2)Looking for participantsNCT06695013
What this trial is testing

Immunobridging/Maintenance Therapy Versus Non-bridging Therapy in CAR-T Therapy for Low-risk R/R B-NHL

Who this might be right for
B-NHLCART Therapy
Ruijin Hospital 144
Early research (Phase 1)Looking for participantsNCT07106749
What this trial is testing

CD180 CART for Relapsed or Refractory CD180 Positive Hematologic Malignancies

Who this might be right for
Acute Myeloid LeukemiaB Acute Lymphoblastic Leukemia/Lymphoma
Institute of Hematology & Blood Diseases Hospital, China 12
Very early researchUnknownNCT03814447
What this trial is testing

The Fourth Generation CART-cell Therapy for Refractory-Relapsed Ovarian Cancer

Who this might be right for
Ovarian Cancer
Shanghai 6th People's Hospital 10
Early research (Phase 1)Study completedNCT03726515
What this trial is testing

CART-EGFRvIII + Pembrolizumab in GBM

Who this might be right for
Glioblastoma
University of Pennsylvania 7
Early research (Phase 1)Looking for participantsNCT06934382
What this trial is testing

Anti-CD7 CAR-T Cells in Relapsed/Refractory T-Cell Acute Lymphoblastic Leukemia or Lymphoma

Who this might be right for
T-Cell Acute Lymphoblastic Leukemia/Lymphoma
Stephan Grupp MD PhD 33
Not applicableLooking for participantsNCT07234110
What this trial is testing

CD5 CART for the Treatment of Relapsed and Refractory CD5 Hematological Tumors

Who this might be right for
Relapsed and Refractory CD5 Hematological Tumors
Institute of Hematology & Blood Diseases Hospital, China 18
Not applicableStudy completedNCT04051216
What this trial is testing

The SMART CART Study: Health Information Technology

Who this might be right for
Leukemia, AcuteLeukemia, Lymphoblastic
University of Michigan Rogel Cancer Center 148
Early research (Phase 1)Looking for participantsNCT06875063
What this trial is testing

GB5005 CART-cell Injection in the Treatment of Patients With CD19-positive RR B-NHL

Who this might be right for
Non-hodgkin LymphomaRefractory LymphomaChimeric Antigen Receptor T-cell
The First Affiliated Hospital of Xiamen University 45
Early research (Phase 1)Ended earlyNCT03448978
What this trial is testing

Autologous CD8+ T-cells Expressing an Anti-BCMA CAR in Patients With Myeloma

Who this might be right for
Multiple Myeloma
Cartesian Therapeutics 32
Not applicableStudy completedNCT04213469
What this trial is testing

PD1-CD19-CART in Patients With r/r B-cell Lymphoma

Who this might be right for
B-cell Lymphoma
Bioray Laboratories 20
Not applicableStudy completedNCT03618862
What this trial is testing

Study of the Effects of Farnesoid X Receptor (FXR) Ligands on the Reactivation of Latent Provirus

Who this might be right for
Hiv
Hospices Civils de Lyon 38
Very early researchNot Yet RecruitingNCT07458659
What this trial is testing

Clinical Study of BCMA-Targeted CAR T-Cell Injection in the Treatment of Patients With Relapsed/Refractory Multiple Myeloma

Who this might be right for
Relapsed/Refractory Multiple Myeloma (MM)
Chulalongkorn University 3
Next Page